tirzepatide weight loss amount Dosage Guide for Loss: Weekly Dosing, Units Calculator, and What Patients Should Know Who Is Tirzepatide Right For?

These common side effects may impact the disease burden of people with type 2 diabetes and negatively affect adherence in all patient groups

Backed by 3 published clinical trials and counting

On average, patients have lost 15% of their body weight through weight loss injections and a diet and exercise program

Your plan is matched to your health history, tolerance, and schedule, with a dosing pace that supports comfort and consistency

Tirzepatide (trade name Mounjaro) is a new glucose-lowering medicine in the incretin family which, to date, has included the glucagon-like peptide-1 (GLP-1) receptor agonists (such as dulaglutide and semaglutide) and dipeptidyl peptidase-4 (DPP-4) inhibitors (including linagliptin and sitagliptin)